This grant supports the Moroccan Agency for Medicines and Health Products (AMMPS) as it transitions into an autonomous national regulatory authority and advances toward higher WHO maturity levels, in line with national reforms and public health priorities.  SHI supports implementation, manages fiduciary processes, and ensures disciplined execution, while AMMPS leadership drives technical direction and ownership.